Suppr超能文献

新辅助放疗后切除与直接切除治疗局部晚期胰腺癌患者的倾向评分匹配分析

Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.

作者信息

Chen Xing, Liu Geng, Wang Kaiqiang, Chen Guodong, Sun Jinjin

机构信息

Department of Hepatopancreatobiliary Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.

出版信息

Oncotarget. 2017 Jul 18;8(29):47831-47840. doi: 10.18632/oncotarget.18091.

Abstract

BACKGROUND AND AIM

To compare cancer-specific survival (CSS) between patients who received neoadjuvant radiation followed by resection (NRR) and those who received upfront resection (UR) for locally advanced pancreatic cancer (LAPC).

METHODS

A total of 772 LAPC patients who underwent curative-intent surgical resection with or without neoadjuvant radiation from 2004 to 2013 were identified from the Surveillance, Epidemiology, and End Result (SEER) database. Propensity score matching (PSM) was conducted to eliminate possible bias. Kaplan-Meier method was used to analyze long-term outcome. Independent risk factors of CSS were predicted by Cox proportional hazards model. Subgroup analyses were done according to 5 variables.

RESULTS

The propensity score model matched 196 patients from the whole cohort. Neoadjuvant radiation was an independent predictor of CSS no matter before or after PSM. After PSM, the 1-, 3-, 5-year CSS rates of NRR group were 82.7%, 39.2% and 17.1%, while 64.3%, 19.9% and 12.4% for UR group. The median CSS for NRR group was 25 months, while 17 months for UR group. In subgroup analyses, CSS rates or median CSS of NRR group were still superior to those of UR group in married, unmarried, pancreatic adenocarcinoma, G1+G2, G3+G4, N0 stage, N1 stage and M0 stage subgroups, but no differences were found in other histological types and M1 stage subgroups. Other predictors of CSS included histological type, tumor grade and marital status.

CONCLUSIONS

Neoadjuvant radiation followed by resection has a significant survival benefit compared with upfront resection in LAPC patients. Therapeutic strategy for LAPC patients should be further explored.

摘要

背景与目的

比较接受新辅助放疗后手术切除(NRR)的局部晚期胰腺癌(LAPC)患者与接受直接手术切除(UR)的患者的癌症特异性生存率(CSS)。

方法

从监测、流行病学和最终结果(SEER)数据库中识别出2004年至2013年期间接受了有或无新辅助放疗的根治性手术切除的772例LAPC患者。采用倾向评分匹配(PSM)以消除可能的偏差。采用Kaplan-Meier法分析长期预后。通过Cox比例风险模型预测CSS的独立危险因素。根据5个变量进行亚组分析。

结果

倾向评分模型从整个队列中匹配出196例患者。无论在PSM之前还是之后,新辅助放疗都是CSS的独立预测因素。PSM后,NRR组的1年、3年、5年CSS率分别为82.7%、39.2%和17.1%,而UR组分别为64.3%、19.9%和12.4%。NRR组的CSS中位数为25个月,而UR组为17个月。在亚组分析中,NRR组的CSS率或CSS中位数在已婚、未婚、胰腺腺癌、G1+G2、G3+G4、N0期、N1期和M0期亚组中仍优于UR组,但在其他组织学类型和M1期亚组中未发现差异。CSS的其他预测因素包括组织学类型、肿瘤分级和婚姻状况。

结论

与直接手术切除相比,新辅助放疗后手术切除对LAPC患者有显著的生存益处。应进一步探索LAPC患者的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b9/5564608/041c0ce7df91/oncotarget-08-47831-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验